West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services Inc.
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Aktie / Ausrüstung & Versorgung / Mid Cap /
212,90 €
-2,47 %
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $405.00 price target on the stock, up previously from $390.00.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $375.00 to $385.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target lowered by analysts at Stephens from $420.00 to $390.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $536.00 price target on the stock, up previously from $323.00.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $440.00 to $470.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $390.00 price target on the stock, up previously from $350.00.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Bank of America Co. from $350.00 to $355.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $250.00 price target on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target lowered by analysts at KeyCorp from $470.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $275.00 price target on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Evercore ISI from $275.00 to $350.00. They now have an "outperform" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $311.00 price target on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its price target raised by analysts at KeyCorp from $325.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) was given a new $345.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) is now covered by analysts at TD Cowen. They set a "buy" rating and a $350.00 price target on the stock.
Ratings data for WST provided by MarketBeat
Neueste Beiträge
Truist_Financial_Co_ in Charles Schwab Corp. diskutieren